| Lineage |
Glia > Oligodendroglia > Oligodendrocyte |
| Markers |
PLP, MBP, CC1, OLIG2, SOX10 |
| Brain Regions |
White matter tracts, Subcortical regions |
| Disease Vulnerability |
[Alzheimer's Disease](/diseases/alzheimers), [Parkinson's Disease](/diseases/parkinsons-disease), [Multiple Sclerosis](/diseases/ms), [PSP](/diseases/psp) |
Myelin-forming oligodendrocytes are the myelin-producing cells of the central nervous system (CNS), responsible for generating the multilamellar myelin sheath that ensheaths axons and enables rapid saltatory conduction. These cells are increasingly recognized as critical players in neurodegenerative diseases beyond their well-established role in multiple sclerosis. Beyond conduction, oligodendrocytes provide essential metabolic support to axons through the lactate shuttle, maintain axonal ion homeostasis, and deliver trophic factors that preserve neuronal integrity. The dysfunction or loss of oligodendrocytes initiates a cascade of axonal degeneration, neural network disruption, and progressive cognitive decline that characterizes neurodegenerative diseases.
White matter abnormalities detected by MRI—including white matter hyperintensities, diffusion tensor imaging changes, and white matter atrophy-represent core pathological features of Alzheimer's disease (AD), Parkinson's disease (PD), and other neurodegenerative disorders. These imaging findings directly reflect oligodendrocyte dysfunction and myelin breakdown, making the study of these cells essential for understanding disease progression and developing therapeutic interventions.
Oligodendrocytes undergo a carefully regulated differentiation program from radial glial or neural stem cell precursors:
-
Oligodendrocyte precursor cells (OPCs): Also known as NG2-positive cells, these proliferate and migrate throughout the CNS white and gray matter. OPCs maintain a proliferative capacity throughout life and can be activated for remyelination. [@young2013]
-
Premature oligodendrocytes: Express early myelin genes including PLP (proteolipid protein) and begin synthesizing myelin components.
-
Mature oligodendrocytes: Fully differentiated cells that produce compact myelin sheaths. A single oligodendrocyte can myelinate up to 60 axonal segments, forming extensive networks of metabolic support.
The myelin sheath is a specialized multilamellar membrane composed of alternating lipid and protein layers:
- Internodes: The main body of the myelin sheath, consisting of compact major dense line (MDL) and intraperiod line (IPL) layers. The number of lamellae determines conduction velocity.
- Nodes of Ranvier: Short unmyelinated gaps (1 μm) between adjacent internodes, containing high-density sodium channels for action potential regeneration.
- Paranodal loops: Helical structures at the axon-oligodendrocyte junction, forming tight junctions that isolate the nodal region.
- Incisures ( Schmidt-Lantermann incisures): Cytoplasmic channels within the myelin sheath allowing metabolic exchange between the oligodendrocyte cell body and innermost lamellae.
The primary function of myelin is to increase the velocity of action potential propagation along axons. By saltatory conduction ("jumping" from node to node), myelinated axons conduct signals up to 50-100 times faster than unmyelinated fibers of equivalent diameter. This enables efficient neural communication across brain regions.
Beyond electrical insulation, oligodendrocytes provide critical metabolic support to axons through a specialized lactate shuttle system: [@lee2012]
- Glycolysis: Oligodendrocytes metabolize glucose to lactate through glycolysis, even under aerobic conditions. [@funfschilling2022]
- Monocarboxylate transport: Lactate is transferred to axons via monocarboxylate transporters (MCTs), specifically MCT1 on oligodendrocytes and MCT2 on axons.
- Oxidative phosphorylation: Axons use lactate as an energy substrate for mitochondrial ATP production.
- Ion homeostasis: Oligodendrocytes help maintain axonal ionic balance, particularly potassium buffering.
This metabolic coupling means that oligodendrocyte dysfunction leads to axonal degeneration even in the absence of overt demyelination. [@rinholm2011]
Oligodendrocytes produce various trophic factors that support axonal health:
- BDNF (brain-derived neurotrophic factor)
- GDNF family members
- IGF-1 (insulin-like growth factor)
Oligodendrocyte dysfunction and myelin breakdown are early features of AD pathogenesis:
- White matter hyperintensities:MRI lesions correlate with cognitive decline and predict progression to dementia. [@prins2015]
- Myelin basic protein alterations: Reduced MBP in AD cerebrospinal fluid reflects demyelination. [@ishii2019]
- Iron accumulation: Myelin breakdown releases iron, which accumulates in white matter and promotes oxidative stress. [@raven2018]
- Amyloid interaction: Amyloid-β binds to oligodendrocytes and impairs their function
- Tau pathology: Oligodendrocytes develop tau inclusions that correlate with white matter damage
- Energy failure: Oligodendrocyte mitochondrial dysfunction contributes to metabolic impairment
- Dying-back degeneration: Axonal degeneration precedes myelin loss in AD
- Remyelination strategies may restore function
- Metabolic support enhancement (lactate shuttle optimization)
- Myelin-protective agents
Oligodendrocyte involvement in PD has received increasing attention: [@barkholt2022]
- Oligodendrocyte loss: Reduced oligodendrocyte numbers in PD substantia nigra
- White matter abnormalities: DTI changes precede motor symptoms
- Iron deposition: Excessive iron in white matter promotes oxidative damage. [@dexter1989]
- Axonal degeneration: Loss of metabolic support from oligodendrocytes contributes to dopaminergic neuron death. [@marz2017]
PSP shows prominent white matter abnormalities: [@axelsen2018]
- Myelin breakdown: Extensive demyelination in subcortical regions
- Tau pathology: Oligodendrocytes contain tau filaments
- Frontal white matter: Severe involvement correlates with executive dysfunction
While MS is primarily considered an autoimmune demyelinating disease, evidence suggests neurodegenerative components: [@trapp2021]
- Primary demyelination: Immune attack on myelin
- Oligodendrocyte death: Direct loss of myelin-producing cells
- Remyelination failure: OPCs fail to differentiate
- Axonal transection: Permanent axonal loss
- White matter changes: Preclinical MRI abnormalities
- OPC failure: Differentiation defects in ALS models
- Metabolic dysfunction: Oligodendrocyte energy failure
| Approach |
Mechanism |
Stage |
| LINGO-1 antagonist |
Block inhibitory signaling |
Clinical trials |
| Clemastine |
OPC differentiation |
Phase 2 |
| Opicinumab |
Anti-LINGO-1 antibody |
Clinical trials |
| Guanabenz |
eIF2α modulation |
Preclinical |
- MCT transporter agonists
- Lactate supplementation
- Mitochondrial protectants
- Antioxidants (N-acetylcysteine)
- Iron chelators (deferoxamine)
- Trophic factor delivery
Recent single-cell RNA-seq studies have revealed:
- Heterogeneous oligodendrocyte populations
- Disease-specific oligodendrocyte subtypes
- Transcriptional signatures of oligodendrocyte dysfunction
Advanced MRI techniques:
- Magnetization transfer ratio (MTR)
- Myelin water imaging
- Diffusion basis spectrum imaging
](/diseases/oligodendrocyte-precursor-cells
--myelin-sheath
--white-matter-lesions
--alzheimers-disease-pathogenesis)## References
- Nave KA, Werner HB. Myelination of axons in the CNS (2023)
- Baumann N, Pham-Dinh D. Biology of oligodendrocytes and myelin (2021)
- Simons M, Nave KA. Oligodendrocytes: myelination and axonal support (2022)
- Funfschilling U, et al. Glycolytic oligodendrocytes maintain myelin (2022)
- Bradl M, Lassmann H. Oligodendrocytes: biology and experimental pathology (2021)
- Franklin RJ, ffrench-Constant C. Remyelination in the CNS (2023)
- Trapp BD, Nave KA. Multiple sclerosis: an immune or neurodegenerative disorder? (2021)
- Rosenberg LJ, et al. Oligodendrocyte progenitor cells in demyelinating diseases (2024)
- Petratos S, et al. Demyelination and remyelination in Alzheimer's disease (2012)
- Ishii T, et al. Myelin basic protein in AD cerebrospinal fluid (2019)
- Raven EP, et al. Accelerated iron accumulation in AD white matter (2018)
- Prins D, Scheltens P. White matter hyperintensities, cognitive decline, and dementia (2015)
- Barkholt P, et al. Oligodendrocyte loss in Parkinson's disease (2022)
- Marz P, et al. Oligodendrocyte vulnerability in Parkinson's disease (2017)
- Axelsen M, et al. Myelin abnormalities in progressive supranuclear palsy (2018)
- Lee Y, et al. Lactate transport and the white matter energy economy (2012)
- Rinholm JE, et al. Regulation of axonal energy by oligodendrocytes (2011)
- Connor JR, Menzies SL. Iron in oligodendrocytes and myelination (1995)